On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdayNov 16, 2022 1:26 pm

NetworkNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Schedules Q3 2022 Earnings Call

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has announced it will release financial numbers for its third quarter 2022 on Nov. 21, 2022, after market close. The company also plans to hold a conference call to discuss the financial results and corporate update report. That call will be held at 10 a.m. ET on Nov. 22, 2022. EverGen CEO Chase Edgelow will host the call. EverGen is an established independent renewable energy producer that acquires, develops, builds, owns and operates a portfolio of renewable natural gas, waste-to-energy and related infrastructure projects. To participate in the…

Continue Reading

TuesdayNov 15, 2022 3:17 pm

NetworkNewsBreaks – CubCrafters Inc. Secures SEC Qualification

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, today announced that it has been qualified by the Securities Exchange Commission (“SEC”) to make a $50 million public stock offering using the Regulation A+ exemption. This allows for the first outside investment ever in the history of this iconic company. Advised by Manhattan Street Capital, CubCrafters intends to raise up to $50 million in investment capital from its fans, customers, aviation enthusiasts, the investment community, and the general public. The offering price for first round investors is $5 per share, with a minimum of…

Continue Reading

TuesdayNov 15, 2022 3:06 pm

NetworkNewsBreaks – Florida Bitcoin & Blockchain Summit Names IBN’s CryptoCurrencyWire as Official NewsWire

The second annual Florida Bitcoin & Blockchain Summit (“FBBS”) has selected InvestorBrandNetwork (“IBN”), a multifaceted communications organization with more than 50 brands including CryptoCurrencyWire (“CCW”), as an official newswire for this year’s event. The summit is hosted by Cutting Edge Events, which made the IBN selection. Cutting Edge Events is an innovative conference organizer specializing in new media and tech-driven events. “IBN and its blockchain-focused newswire have both repeatedly demonstrated that they are highly adept at maximizing coverage of our events and leaders in delivering our message effectively,” said Cutting Edge Events founder Chris Krimitsos in the press release. “IBN’s…

Continue Reading

TuesdayNov 15, 2022 2:30 pm

NetworkNewsBreaks – HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE) (TSX.V: HIVE) (FSE: HBFA) Announces Quarterly Revenue of $29.6M, 31% YOY Increase in Bitcoin Production

HIVE Blockchain Technologies (NASDAQ: HIVE) (TSX.V: HIVE) (FSE: HBFA), a leading digital asset miner and green-focused data center builder and operator, today announced the earnings report for the second quarter ended Sept. 30, 2022. Among the highlights, HIVE announced that it achieved revenue of $29.6 million this quarter, through mining 858 green and clean Bitcoin and 7,309 Ethereum, which were subsequently sold to reinvest in new ASIC mining equipment. As such, HIVE’s production of Bitcoin increased by 4.5% quarter over quarter while its average daily production of Ethereum increased from 84.3 ETH per day to 94.9 ETH this quarter, prior…

Continue Reading

TuesdayNov 15, 2022 2:20 pm

NetworkNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) ‘Strikingly Different’ EV Crossover Tour Takes the Spotlight in Vegas, Heads to Texas

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has successfully completed the third stop of the Mullen FIVE Strikingly Different EV Crossover Tour in Las Vegas, Nevada. According to the announcement, Mullen continues onwards to Texas, with stops this week in Dallas and Houston. The Mullen FIVE EV vehicle on tour is equipped with a completely updated infotainment system that features PERSONA, Mullen’s proprietary Personal Vehicle Assistant (“PVA”), which utilizes facial recognition technology to provide every driver with a highly individualized experience. “This tour not only allows the public to see what Mullen has…

Continue Reading

TuesdayNov 15, 2022 2:06 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Announces Upcoming Annual Meeting of Stockholders

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a medical technology company focused on developing unique, life-saving medical products, has scheduled its Annual Meeting of Stockholders; the meeting is slated for Jan. 12, 2023. According to the announcement, any proposals to be considered for the meeting should be sent to the company’s principal executive offices in Las Vegas; all proposals must comply with the procedures for stockholder proposals in the company's bylaws and need to be received by the close of business on Nov. 25, 2022. The company will file the official Notice of Annual Meeting and Proxy Statement…

Continue Reading

TuesdayNov 15, 2022 1:54 pm

NetworkNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Q3 2022 Results, Provides Corporate Update

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases, today announced financial results for the third quarter ended Sept. 30, 2022, and provided a corporate update. “Initial, preliminary data from our second patient dosed with CycloSam continues to show positive signals in terms of safety and efficacy. While it is too early for formal conclusions to be made of these results, CycloSam generally performed how we expected it to perform, even given the lowest dosage in our dose-escalating study. This is all very encouraging,” said Douglas R.…

Continue Reading

TuesdayNov 15, 2022 1:40 pm

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Congratulates Dirk Görlich on $1.4M World Laureates Association Prize in Life Sciences

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company today congratulated its co-lead scientific research collaborator Professor Dr. Dirk Görlich, director at the Max Planck Institute for Multidisciplinary Sciences (“MPI”), on being awarded the inaugural $1.4 million World Laureates Association (“WLA”) Prize in Life Sciences or Medicine for his seminal work describing protein transport within the cell. “On behalf of BiondVax’s team, I wish to offer my sincere congratulations to Dirk on being awarded the inaugural WLA Prize in Life Sciences. The…

Continue Reading

TuesdayNov 15, 2022 1:26 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Q2 Results, Recent Business Highlights, Presentation of CYB003 Preclinical Data at Neuroscience 2022

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), has reported unaudited financial results for its second quarter ended Sept. 30, 2022, as well as recent business highlights. “We have continued to make progress as planned, advancing our clinical pipeline of modified psychedelic-based molecules while also strengthening our drug discovery platform of differentiated preclinical compounds,” said Cybin’s CEO Doug Drysdale. “In addition to our clinical work, we have been actively broadening our robust IP portfolio through securing strategic licensing agreements for preclinical psychedelic-based compounds that will support our ongoing drug development efforts. These recent…

Continue Reading

TuesdayNov 15, 2022 12:56 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports Multimillion-Dollar Claim Has Been Dismissed

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, has announced that a $30.2 million claim against the company has been dismissed. The claim was filed against the company by its former CEO, Dr. Raza Bokhari. In the claim, Bokhari asserted that he had been wrongfully dismissed from his position at FSD Pharma. An arbitrator evaluated the claim and ruled that it should be dismissed. In addition, Bokhari was ordered by the arbitrator to pay a certain amount to FSD Pharma…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217